Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved ...

ACA marketplace premiums are projected to rise by 26% in 2026, with potential further increases if premium tax credits expire ...

RSV vaccination for adults aged 60+ could prevent significant LRTD cases, hospitalizations, and deaths over five years. A ...

Phung explained that prior response often guides selection: Patients who respond poorly to frontline therapy may move to CAR ...

Metabolic reprogramming in fibrotic lung diseases involves key metabolites like lactate, succinate, and 2-hydroxyglutarate, ...

Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and ...

Across conversations on precision oncology, malignant hematology, cellular therapies, and social determinants of health (SDOH ...

Brigid Groves, PharmD, MS, discusses the importance of using trustworthy sources so that pharmacists can support communities ...

It is necessary to balance rigorous clinical trials with real-world evidence (RWE) to show how data from everyday practice ...

1. Garg S, Donnenfeld E, Sheppard J, Epitropoulos A, Brady TC. Reproxalap improves ocular redness, tear production, and ...

Innovative cancer therapies are transforming treatment landscapes, yet access challenges persist. Experts discuss strategies ...

B/F/TAF shows lower ART switching rates and higher persistence among HIV patients, especially those with mental health or ...